IBM Watson Health plans to acquire Truven Health Analytics for $2.6 billion, a deal which upon completion will aggregate health-related data of approximately 300 million patient lives.
Truven Health Analytics provides cloud-based healthcare data, analytics and insights for more than 8,500 clients, including U.S. federal and state government agencies, employers, health plans, hospitals, clinicians and life science companies.
The acquisition is IBM Watson's fourth health-related agreement since the Watson Health unit was launched in April 2015.
Additionally, more than 5,000 Truven employees will join the IBM business unit, including clinicians, epidemiologists, statisticians and more.
"With this acquisition, IBM will be one of the world's leading health data, analytics and insights companies, and the only one that can deliver the unique cognitive capabilities of the Watson platform," said Deborah DiSanzo, general manager for Watson Health. "Truven's impressive team, extensive client roster and expansive data sets complement Watson Health's broad-based team, capabilities and offerings. Together, we're well positioned to scale globally and to build first-in-class offerings designed to help our clients apply cognitive insights in a value-based care environment."
The acquisition is expected to close later this year.
More articles on IBM Watson:
Harvard, IBM Watson, Anthem Blue Cross & GenieMD forge patient app partnership
IBM Watson exec leaves after 9 months on the job
IBM Watson Health, American Heart Association & Welltok collaborate on heart health project